Business
Tenaya Therapeutics to Participate in Upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and
About this update from Tenaya Therapeutics, Inc.
[{"type":"text","content":" SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--\nTenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, announced today that Faraz Ali, Chief Executive Officer, will participate in the following conference:\n\n33rd Annual Piper Sandler Healthcare Conference\nNovember 29 – December 2, with a fireside chat webcast available beginning Monday, November 22, 2021 at 10:00 a.m. ET / 7:00 a.m. PT\n\nAbout Tenaya Therapeutics\n\nTenaya Therapeutics is a biotechnology company committed to a bold mission: to discover, develop and deliver curative therapies that address the underlying drivers of heart disease. Founded by leading cardiovascular scientists from Gladstone Institutes and the University of Texas Southwestern Medical Center, Tenaya is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. For more information, visit www.tenayatherapeutics.com.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20211119005241/en/\n\nInvestors:\nLeone Patterson\nTenaya Therapeutics\[email protected]\n\nMedia:\nWendy Ryan\nTen Bridge Communications\[email protected]\n\nSource: Tenaya Therapeutics, Inc.","length":3443,"tagName":"div"}]